Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0fee919b25f67af4712af4db7b3381f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e482dae8f4f767034149618ed513151 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c084056c30ccfb0be7ddca590a7c1c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22b1673638db2579a1be473ac139f6c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed0305fbf9c5fa5cc0aaaf73fd670d54 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-02 |
filingDate |
2004-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdedcdfbc6417d118d0e279ee8081f98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0244399ba9e252ab13199a20cb10d320 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c38c37261dcfe69d69ec78496980e636 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d25da1e30302d8d487c642e86350a49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e98ffbab145fcfa6c41298b1fdb2b9d2 |
publicationDate |
2007-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007027188-A1 |
titleOfInvention |
Ophthalmic compositions for treating ocular hypertension |
abstract |
This invention relates to potent potassium channel blocker compounds of structural Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006020000-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7528163-B2 |
priorityDate |
2003-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |